Dr. Michelle Rene Reisner, MD

Dr. Reisner practices at RWJBH Primary Care Services in Old Bridge, New Jersey.

Dr. Reisner's NPI, 1942267158, was assigned on May 1, 2006. Dr. Reisner holds New Jersey license 25MA05092900.

Dr. Reisner's primary practice is RWJBH Primary Care Services, at 2101 County Route 516, Old Bridge, NJ 08857 in Middlesex County. The practice phone is (732) 867-9618.

Dr. Reisner's primary practice is RWJBH Primary Care Services in Old Bridge, New Jersey. Dr. Reisner is also affiliated with Jersey City Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Reisner to 5 more group practices and clinics, 5 medical groups, 4 home health agencies, 3 skilled nursing facilities, 1 physician office and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reisner practices, 15 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Reisner's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Reisner is licensed in New Jersey.

CMS data shows 1,872 Medicare services from Dr. Reisner across 22 procedure codes in 2024, for 333 Medicare patients. Medicare paid $144,674 for them.

CMS counts 333 Medicare patients who saw Dr. Reisner in 2024. The largest group is 75 to 84, with 116 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reisner's median patient age at 80, with 70% women.

In 2024, Dr. Reisner wrote 13,717 Medicare Part D claims for 927 patients. 83% of them were for generic drugs. CMS names the drug for 12,732 of them, across 192 drugs with 11 or more claims each, at $1,375,928 in total drug cost. In 2023, CMS named 16,169 claims across 215 drugs.

Dr. Reisner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reisner as offering telehealth.

Dmand AI links 2 papers to Dr. Reisner. Dr. Reisner's most frequent co-authors are Haroon Latif Chughtai, MD and Nitesh D. Kuhadiya, MD, MPH.

CMS Open Payments shows 38 general payments to Dr. Reisner from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $275.